 | Ferdinando Riccardi |
Prominent publications by Ferdinando Riccardi
Purpose To test the efficacy of adding cisplatin to first-line treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) within a combined analysis of two parallel phase III trials, MILES-3 and MILES-4. Patients and Methods Patients with advanced NSCLC who were older than age 70 years with Eastern Cooperative Oncology Group performance status 0 to 1 were randomly assigned to gemcitabine or pemetrexed, without or with cisplatin. In each trial, 382 events were ...
| Also Ranks for: Elderly Patients | cell lung | joint analysis | life cisplatin | advanced nsclc |
PURPOSE: Erlotinib prolonged survival of unselected patients with advanced non-small-cell lung cancer (NSCLC) who were not eligible for further chemotherapy, and two phase II studies suggested it might be an alternative to first-line chemotherapy. A randomized phase III trial was designed to test whether first-line erlotinib followed at progression by cisplatin-gemcitabine was not inferior in terms of survival to the standard inverse sequence.
PATIENTS AND METHODS: Patients with stage ...
| Also Ranks for: Cell Lung | experimental arm | unselected patients | firstline erlotinib | terms survival |
Ferdinando Riccardi: Influence Statistics
| Concept | World rank |
|---|---|
| torch randomized | #26 |
| trials miles3 | #29 |
| standard inverse sequence | #30 |
| analysis miles3 | #39 |
| miles3 miles4 | #43 |
| miles4 patients | #46 |
| miles3 | #48 |
| miles4 | #49 |
Key People For Life Cisplatin
Ferdinando Riccardi:Expert Impact
Concepts for whichFerdinando Riccardihas direct influence:Life cisplatin, Advanced nsclc, Cell lung, Experimental arm, Unselected patients, Firstline erlotinib, Miles3 miles4, Firstline chemotherapy.
Ferdinando Riccardi:KOL impact
Concepts related to the work of other authors for whichfor which Ferdinando Riccardi has influence:Cell lung, Egfr mutations, Acquired resistance, Kinase inhibitors, Nsclc patients, Epidermal growth, Carcinoma small.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |